RSPO1 and cancer: Even though there are some differences between Wnt mimetics and mutations found in cancer, for example, Wnt mimetics induced signaling may differ from intracellular activating mutations in amplitude and duration, as Wnt mimetics activate only a subset of Fzds and Wnt mimetics do not directly affect R-Spondins to further enhance signaling.